Swiss medtech company Ypsomed is making its first major move into the US market with a $220 million manufacturing facility in Holly Springs, North Carolina. The site, set to begin operations by 2027, will produce injection systems for self-medication and marks a significant step in the company’s global expansion strategy. The post Swiss medtech giant Ypsomed expands to US with $220M facility in North Carolina appeared first on Manufacturing Today.| Manufacturing Today